Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    0(0%)

    Phase Distribution

    Phase 4
    1
    50%
    Phase 2
    1
    50%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    1

    Late Stage

    Phase Distribution2 total trials
    Phase 2Efficacy & side effects
    1(50.0%)
    Phase 4Post-market surveillance
    1(50.0%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 1 finished

    Non-Completion Rate

    100.0%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Terminated(1)
    Other(1)

    Detailed Status

    Suspended1
    Withdrawn1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    N/A
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 21 (50.0%)
    Phase 41 (50.0%)

    Trials by Status

    suspended150%
    withdrawn150%

    Recent Activity

    0 active trials
    Showing 2 of 2
    suspendedphase_2

    Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment

    NCT05427630
    withdrawnphase_4

    Effects of THC and Alcohol on Driving Performance

    NCT03555968

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT05427630Phase 2

    Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment

    Suspended
    NCT03555968Phase 4

    Effects of THC and Alcohol on Driving Performance

    Withdrawn

    All 2 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    2